Learning Curve for Gastric Endoscopic Submucosal Dissection

Status Completed

Clinical Trial Summary

Endoscopic submucosal dissection (ESD) for early gastric cancer is a widely accepted treatment option of expanded indication worldwide. ESD is relatively difﬁcult compared with endoscopic mucosal resection, thus, proper training is essential for the safe performance of the procedure. Thus, it is necessary to receive proper training in the procedure for safe performance of ESD. Previous studies reported that there was a learning curve in ESD training and preceptees needed to perform at least 30-40 procedures in order to master this technique. However, there is few study about the association between the clinical characteristics and competence level for gastric ESD.

Clinical Trial Description

This study aims to evaluate the clinical outcomes of ESD and to describe the learning curve for ESD of the gastric neoplasm, based on the analysis of a single endoscopist's experience. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05265221
Study type	Observational
Source	Soonchunhyang University Hospital
Contact
Status	Completed
Phase
Start date	March 1, 2022
Completion date	May 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02543411` - Use of Lidocaine in Endoscopic Submucosal Dissection	N/A
Completed	`NCT02128243` - Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer	Phase 2
Active, not recruiting	`NCT00506207` - A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy	Phase 1
Completed	`NCT04830618` - Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms
Completed	`NCT02235246` - The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study	Phase 4
Completed	`NCT00252161` - A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer	Phase 3
Recruiting	`NCT04622098` - Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt
Terminated	`NCT01870791` - Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer	Phase 2
Completed	`NCT03255070` - A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)	Phase 1
Recruiting	`NCT06342427` - Stomach Cancer Exosome-based Detection
Recruiting	`NCT04780256` - Endoscopic Resection of Gastrointestinal Neoplasms
Recruiting	`NCT03065257` - Endoscopic Resection Multicenter Registry	N/A
Recruiting	`NCT05804331` - The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Recruiting	`NCT03597581` - A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in 2nd Line RAS Mutant Advanced Colorectal Cancer	Phase 1
Completed	`NCT00112099` - GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110	Phase 3
Recruiting	`NCT04466631` - Health and Employment After Gastro Intestinal Surgery - HEAGIS2
Terminated	`NCT00149266` - Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)	Phase 3
Completed	`NCT00149279` - A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer	Phase 3
Recruiting	`NCT06362070` - Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy	N/A
Completed	`NCT01824953` - Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years	N/A